Genmab A/S Files 6-K, Incorporates into S-8 Filings
Ticker: GNMSF · Form: 6-K · Filed: Apr 15, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, registration-statement
TL;DR
Genmab filed a 6-K on 4/15/25, adding it to their S-8 filings. Standard procedure.
AI Summary
Genmab A/S filed a Form 6-K on April 15, 2025, to report information as a foreign private issuer. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
Why It Matters
This filing ensures that Genmab's registration statements remain current by incorporating new information, which is crucial for ongoing stock-based compensation plans.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not appear to contain new material financial or operational information.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
- 333-284876 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to furnish information that the registrant makes or is required to make public in its home country, files or is required to file with any stock exchange on which its securities are traded, or distributes or is required to distribute to its security holders.
What does it mean for this 6-K to be 'incorporated by reference'?
When a document is incorporated by reference, it means that the SEC filings (in this case, the S-8 registration statements) are treated as if the information from the 6-K filing was included directly within them.
What are Form S-8 registration statements used for?
Form S-8 is a registration statement used by companies to register securities to be offered to employees pursuant to employee benefit plans.
What is the filing date of this Form 6-K?
This Form 6-K was filed on April 15, 2025.
What is the principal executive office address of Genmab A/S?
The address of Genmab A/S's principal executive offices is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 15, 2025 regarding GENMAB A/S (GNMSF).